Strategic Antibody Outsourcing: Guidance On Selection, Services, And Facility Fit
In biologics outsourcing, finding the right CDMO can feel like the Goldilocks dilemma—too few or too many options can be equally challenging. Just as Goldilocks sought what was "just right," antibody developers must balance capabilities and contracts to find the ideal CDMO for their needs.
How do you choose the best CDMO for your program? What technologies and skills matter most? Can your CDMO meet both short- and long-term goals? How do you ensure their facility aligns with your project throughout development?
Join Outsourced Pharma and experts from Mabion as they share insights and best practices on selecting, qualifying, and managing CDMO partnerships. Topics include outsourcing decisions, early planning for scale-up, and commercialization.
Key Discussion Points:
- Selecting a CDMO with facilities tailored to your project
- Building successful CDMO partnerships
- Optimizing RFPs and evaluating pricing
- Balancing internal and external assessments
- Using your CDMO as a strategic advisor
This session will provide the insights you need to find the "just right" CDMO for your biologics program.
Get unlimited access to:
Enter your credentials below to log in. Not yet a member of Bioprocess Online? Subscribe today.